Spiriva Respimat

Spiriva Respimat Tác dụng không mong muốn

tiotropium bromide

Nhà sản xuất:

Boehringer Ingelheim
Thông tin kê toa chi tiết tiếng Anh
Side Effects
Many of the listed undesirable effects can be assigned to the anticholinergic properties of SPIRIVA RESPIMAT.
Adverse drug reactions were identified from data obtained in clinical trials and spontaneous reporting during post approval use of the drug.
The clinical trial database for COPD includes 3,282 SPIRIVA RESPIMAT patients from 7 placebo-controlled clinical trials with treatment periods ranging between four weeks and one year, contributing 2,440 person years of exposure.
The clinical trial database for asthma includes 1,256 tiotropium treated patients from 6 placebo controlled trials with treatment period ranging between twelve weeks and one year, contributing 705 person years of exposure to tiotropium.
Metabolism and nutrition disorders: dehydration.
Nervous system disorders: dizziness, headache, insomnia.
Eye disorders: glaucoma, intraocular pressure increased, vision blurred.
Cardiac disorders: atrial fibrillation, palpitations, supraventricular tachycardia, tachycardia.
Respiratory, thoracic and mediastinal disorders: cough, epistaxis, pharyngitis, dysphonia, bronchospasm, laryngitis, sinusitis.
Gastrointestinal disorders: dry mouth, usually mild; constipation, oropharyngeal candidiasis, dysphagia, gastrooesophageal reflux disease, gingivitis, glossitis, stomatitis, intestinal obstruction incl. ileus paralytic, nausea.
Skin and subcutaneous tissue disorders, Immune system disorders: rash, pruritus, angioneurotic oedema, urticaria, skin infection and skin ulcer, dry skin, hypersensitivity (including immediate reactions), Anaphylactic reaction.
Musculoskeletal and connective tissue disorders: joint swelling.
Renal and urinary disorders: urinary retention (usually in men with predisposing factors), dysuria, urinary tract infection.
Inform the Doctor of any side effect that occur during treatment.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in